Journal of Thrombosis and Thrombolysis

, Volume 31, Issue 2, pp 209–210 | Cite as

The validity of the INR system for patients with liver disease



  1. 1.
    Wei Y, Li J, Zhang L, Zheng D, Shi B, Cong Y (2010) Assessment of validity of INR system for patients with liver disease associated with viral hepatitis. J Thromb Thrombolysis 30:84–89CrossRefPubMedGoogle Scholar
  2. 2.
    Trotter JF, Brimhall B, Arjal R (2004) Specific laboratory methodologies achieve higher model for end stage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transplant 10:995–1000CrossRefGoogle Scholar
  3. 3.
    Kovacs MJ, Wong A, MacKinnon K, Weir K, Keeney M, Boyle E, Cruickshank M (1994) Assessment of the validity of the INR system for patients with liver impairment. Thromb Hemost 71:727–730Google Scholar
  4. 4.
    Denson KW, Reed SV, Haddon ME, Woodhams B, Brucato C, Ruiz J (1999) Comparative studies of rabbit and human recombinant tissue factor reagents. Thromb Res 94:255–261CrossRefPubMedGoogle Scholar
  5. 5.
    Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell’Era A, Sei C, Mannucci PM (2007) The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 46:520–527CrossRefPubMedGoogle Scholar
  6. 6.
    Bellest L, Eschwege V, Poupon R, Chazouillères O, Robert A (2007) A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology 46:528–534CrossRefPubMedGoogle Scholar
  7. 7.
    Sermon AM, Smith JM, Maclean R, Kitchen S (2010) INR in liver disease: an ISI derived from liver disease patients improves agreement between INRs with different reagents. Thromb Haemost 103:757–765PubMedGoogle Scholar
  8. 8.
    Tripodi A, Chantarangkul V, Primignani M, Dell’Era A, Clerici M, Iannuzzi F, Aghemo A, Cazzaniga M, Salerno F, Mannucci PM (2009) Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score. J Hepatol 51:288–295CrossRefPubMedGoogle Scholar
  9. 9.
    Tripodi A, Chantarangkul V, Mannucci PM (2008) The international normalized ratio to prioritize patients for liver transplantation. Problems and possible solutions. J Thromb Haemost 6:243–248PubMedGoogle Scholar
  10. 10.
    Tripodi A, Baglin T, Robert A, Kitchen S, Lisman T, Trotter JF, on behalf of the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis (2010) Reporting prothrombin time results as international normalised ratios for patients with chronic liver disease. J Thromb Haemost 8:1410–1412Google Scholar
  11. 11.
    Porte RG, Lisman T, Tripodi A, Caldwell SH, Trotter JF, and the Coagulation in Liver Disease Study Group (2010) The international normalized ratio (INR) in the MELD score: problems and solutions. Am J Transplant 10:1349–1353CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Internal Medicine, Angelo Bianchi Bonomi Hemophilia and Thrombosis CenterIRCCS Cà Granda Ospedale Maggiore Policlinico Foundation and Università degli Studi di MilanoMilanItaly

Personalised recommendations